Takeda Pharmaceutical TAK
NYSE TAK
$18.20 -0.31 (-1.65%)
As of: Sep 30, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Short term Debt (2018 - 2026)

Updated

Takeda Pharmaceutical's Short term Debt came in at $690.85 million for the quarter ended Jun 30, 2026, down 51.3% from $1.42 billion a year earlier and down 23.3% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Short term Debt (2018 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical's Short term Debt was $938.15 million, down 34.8% from the prior year.

  • Short term Debt carries a five-year compound annual growth rate of -16.7% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Short term Debt was $1.44 billion in the year ended Mar 31, 2025 (+44.6%), $994.5 million in the year ended Mar 31, 2024 (-27.6%), $1.37 billion in the year ended Mar 31, 2023 (-21.4%) and $1.75 billion in the year ended Mar 31, 2022 (-25.4%).
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Short term Debt since the quarter ended Nov 29, 2019.
  • Year-over-year, Short term Debt increased in three of the last eight quarters, with an average decline of 8.9%.
  • The fastest year-over-year change in Short term Debt over five years came in the quarter ended Sep 30, 2023 (growth of 160.1%), and the weakest in the quarter ended Jun 30, 2026 (a decline of 51.3%).
  • Business Quant data shows TAK's Short term Debt at $900.5 million (quarter ended Mar 31, 2026), $1.76 billion (quarter ended Dec 31, 2025) and $1.53 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.68 Bn -23.83 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 690.85 Mn
Mar 31, 2026 900.50 Mn
Dec 31, 2025 1.76 Bn
Sep 30, 2025 1.53 Bn
Jun 30, 2025 1.42 Bn
Mar 31, 2025 1.44 Bn
Dec 31, 2024 1.42 Bn
Sep 30, 2024 1.36 Bn
Jun 30, 2024 1.70 Bn
Mar 31, 2024 967.78 Mn
Dec 31, 2023 1.68 Bn
Sep 30, 2023 2.13 Bn
Jun 30, 2023 2.29 Bn
Mar 31, 2023 1.40 Bn
Dec 31, 2022 1.28 Bn
Sep 30, 2022 818.75 Mn
Jun 30, 2022 1.08 Bn
Mar 31, 2022 1.69 Bn
Jun 30, 2021 2.13 Bn
Mar 31, 2021 2.34 Bn
API Access

Takeda Pharmaceutical Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TAK&period=max&api_key=YOUR_API_KEY